Keeping the biotechnology of antisense in context
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tu et al. (47) have performed a comprehensive survey of the literature, leading Stein (48) to estimate that non-sequence-selective effects may be at least partially implicated in results reported in 94% of the 2,026 studies published through 1997.”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [48]
Citations
Cites
Guvakova, M. A., Yakubov, L. A., Vlodavsky, I., Tonkinson, J. L., & Stein, C. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2620 · Cited by 326
Self-citationDean, N. M., McKay, R., Condon, T. P., & Bennett, C. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34023-1 · Cited by 291
Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
Monia, B. P., Johnston, J. F., Ecker, D. J., Zounes, M. A., Lima, W. F., & Freier, S. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88650-7 · Cited by 254
Applied antisense oligonucleotide technology
Stein, C. A., & Krieg, A. Μ. (1998) · Cited by 148
Self-citationRockwell, P., O’Connor, W. J., King, K. D., Goldstein, N. I., Zhang, L.-M., & Stein, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6523 · Cited by 120
Self-citationTetranucleotide GGGA Motif in Primary RNA Transcripts
Tu, G.-C., Cao, Q.-N., Zhou, F., & Israel, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25125 · Cited by 93
Giles, R. V., Ruddell, C. J., Spiller, D. G., Green, J. A., & TIDD, D. M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.6.954 · Cited by 83
Benimetskaya, L., Berton, M., Kolbanovsky, A., Benimetsky, S., & Stein, C. A. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2648 · Cited by 73
Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides
Benimetskaya, L., Takle, G. Β., Vilenchik, M., Lebedeva, I., Miller, P., & Stein, C. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.23.5310 · Cited by 65
Self-citationOptimization of antisense oligodeoxynucleotide structure for targeting bcr-abl mRNA
Giles, R., Spiller, D. G., Green, J. A., Clark, R. E., & TIDD, D. M. (1995) · Blood · doi:10.1182/blood.v86.2.744.bloodjournal862744 · Cited by 52
Cited by
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Shen, X., & Corey, D. R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1239 · Cited by 632
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5633 · Cited by 520
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA
Braasch, D. A., & Corey, D. R. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00058-2 · Cited by 605
Herbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539
Novel Antisense and Peptide Nucleic Acid Strategies for Controlling Gene Expression
Braasch, D. A., & Corey, D. R. (2002) · Biochemistry · doi:10.1021/bi0122112 · Cited by 248
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs
Sazani, P., Kang, S.-H., Maier, M. A., Wei, C., Dillman, J., Summerton, J., Manoharan, M., & Kole, R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.19.3965 · Cited by 212
Reexamining assumptions about miRNA-guided gene silencing
Kilikevicius, A., Meister, G., & Corey, D. R. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1256 · Cited by 194
Morpholino antisense oligonucleotides: tools for investigating vertebrate development.
Corey, D. R., & Abrams, J. (2001) · Genome biology · doi:10.1186/gb-2001-2-5-reviews1015 · Cited by 229
Ding, Y. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.5.1034 · Cited by 161
Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids
Janowski, B. A., Kaihatsu, K., Huffman, K. E., Schwartz, J. C., Ram, R., Hardy, D., Mendelson, C. R., & Corey, D. R. (2005) · Nature Chemical Biology · doi:10.1038/nchembio724 · Cited by 158
Doyle, D. F., Braasch, D. A., Simmons, C. G., Janowski, B. A., & Corey, D. R. (2000) · Biochemistry · doi:10.1021/bi0020630 · Cited by 168
Bo, X., & Wang, S. (2004) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti211 · Cited by 140
“Even with careful design, typically 20% of AOs are effective (Stein, 1999).”
Antisense therapeutics: is it as simple as complementary base recognition?
Agrawal, S., & Kandimalla, E. R. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01638-x · Cited by 166
Sahu, B., Chenna, V., Lathrop, K. L., Thomas, S. M., Zon, G., Livak, K. J., & Ly, D. H. (2009) · The Journal of Organic Chemistry · doi:10.1021/jo802211n · Cited by 108
Yeh, J. I., Shivachev, B., Rapireddy, S., Crawford, M. J., Gil, R. R., Du, S., Madrid, M., & Ly, D. H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja907225d · Cited by 104
Frameworks for transformational breakthroughs in RNA-based medicines
Androsavich, J. R. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00943-2 · Cited by 108
“Despite warnings, poor practices and questionable findings have persisted 217,240,244–251 .”
Dragulescu-Andrasi, A., Rapireddy, S., He, G.-F., Bhattacharya, B., Hyldig-Nielsen, J. J., Zon, G., & Ly, D. H. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063383v · Cited by 78
Lakkaraju, A., Dubinsky, J. M., Low, W. C., & Rahman, Y.-E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100138200 · Cited by 81
Dragulescu‐Andrasi, A., Zhou, P., He, G., & Ly, D. H. (2004) · Chemical Communications · doi:10.1039/b412522c · Cited by 85
Recognition of Chromosomal DNA by PNAs
Kaihatsu, K., Janowski, B. A., & Corey, D. R. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.014 · Cited by 88
Antisense technology in molecular and cellular bioengineering
Lee, L. K., & Roth, C. M. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00115-0 · Cited by 73
Lok, C., Viazovkina, E., Min, K., Nagy, E., Wilds, C. J., Damha, M. J., & Parniak, M. A. (2002) · Biochemistry · doi:10.1021/bi0115075 · Cited by 70
Guidelines for experiments using antisense oligonucleotides and double-stranded RNAs
Gagnon, K. T., & Corey, D. R. (2019) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0772 · Cited by 59
Morpholino phosphorodiamidate oligonucleotides in zebrafish: A recipe for functional genomics?
Sumanas, S., & Larson, J. D. (2002) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/1.3.239 · Cited by 73
In vivo imaging with oligonucleotides for diagnosis and drug development
Tavitian, B. (2003) · Gut · doi:10.1136/gut.52.suppl_4.iv40 · Cited by 68
Parekh‐Olmedo, H., Drury, M. D., & Kmiec, E. B. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00236-3 · Cited by 54
Antitumor Effects of EGFR Antisense Guanidine-Based Peptide Nucleic Acids in Cancer Models
Thomas, S. M., Sahu, B., Rapireddy, S., Bahal, R., Wheeler, S., Procopio, E. M., Kim, J., Joyce, S. C., Contrucci, S., Wang, Y., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb3003946 · Cited by 53
Allawi, H. T., Dong, F., Ip, H. S., Neri, B. P., & Lyamichev, V. I. (2001) · RNA · doi:10.1017/s1355838201001698 · Cited by 43
“…showing significant inhibition of gene expression out of every 18–20 tested (Monia et al+, 1992; Dean et al+, 1994; Matveeva et al+, 1998; Stein, 1999)+ To address this problem, several experimental and theoretical approaches have been developed for identifying accessible regions in…”
BackgroundIncreased uptake of antisense oligonucleotides by delivery as double stranded complexes
Astriab‐Fisher, A., Fisher, M. H., Juliano, R. L., & Herdewijn, P. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.040 · Cited by 37
Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5
Bahal, R., McNeer, N. A., Ly, D. H., Saltzman, W. M., & Glazer, P. M. (2013) · Artificial DNA PNA & XNA · doi:10.4161/adna.25628 · Cited by 39
Ito, T. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg374 · Cited by 32
Radiolabeled Oligonucleotides for Antisense Imaging
Iyer, A. K., & He, J. (2011) · Current Organic Synthesis · doi:10.2174/157017911796117241 · Cited by 29
“Furthermore, the complex 3Dstructures formed by RNAs such as stem-loop or hairpin structures impose conformational restrictions to hybridization with the complementary strand in vivo [92, 93].”
InfluentialEfficient and Isoform-Selective Inhibition of Cellular Gene Expression by Peptide Nucleic Acids
Liu, Y., Braasch, D. A., Nulf, C. J., & Corey, D. R. (2004) · Biochemistry · doi:10.1021/bi0358519 · Cited by 28
Artificial neural network prediction of antisense oligodeoxynucleotide activity
Giddings, M. C. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf557 · Cited by 24
ODNBase—a web database for antisense oligonucleotide effectiveness studies
Giddings, M. C., Matveeva, O. V., Atkins, J. F., & Gesteland, R. F. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.9.843 · Cited by 22
“However, utilization of antisense ODNs have been hampered by the difficulty in predicting effective ODN target sites and understanding what constitutes an effective antisense molecule (Branch, 1998; Stein, 1999).”
BackgroundPriti, P., Mukherjee, S. K., & Ghosh, A. (2022) · Pathogens · doi:10.3390/pathogens11111319 · Cited by 22
Crawford, M. J., Rapireddy, S., Bahal, R., Sacui, I., & Ly, D. H. (2011) · Journal of Nucleic Acids · doi:10.4061/2011/652702 · Cited by 20
“It is, therefore, important to be able to modify the structures and/or chemical functionalities of these reagents further, with ease and flexibility, so that many of these desired features could be augmented and/or improved upon [9, 10] and undesired attributes, such as nonspecific binding and toxicity, could be furth…”
BackgroundEngdahl, H. M., Lindell, M., & Wagner, E. G. H. (2001) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729001750072100 · Cited by 19
“A NTISENSE RNA AND DNA ( OLIGODEOXYRIBONUCLEOTIDES , ODN) approaches have recently attracted much interest, particularly for biomedical and biotechnologic applications (Crooke, 2000; Matteucci and Wagner, 1996; Nellen and Licht-enstein, 1993; Oberstrass and Nellen, 1997; Stein, 1999).”
Jacob, K. K., & Stanley, F. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102826200 · Cited by 20
ten Asbroek, A. L. M. A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.5.1133 · Cited by 16
AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets
Zhang, C., Owen, L. A., Lillvis, J. H., Zhang, S. X., Kim, I. K., & DeAngelis, M. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061484 · Cited by 20
Kaushik, N., & Pandey, V. N. (2002) · Virology · doi:10.1006/viro.2002.1630 · Cited by 17
“, 1993), unlike oligonucleotides, which are often confounded by nonspecific interactions (Stein, 1999).”
BackgroundBrukner, I. B., & Tremblay, G. A. (2000) · Biochemistry · doi:10.1021/bi000558j · Cited by 15
Ueno, Y., Kato, Y., Okatani, S., Ishida, N., Nakanishi, M., & Kitade, Y. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020072a · Cited by 13
Shang, X., Wang, Y., Zhao, Q., Wu, K., Xu, L., Ji, X., He, R., & Zhang, W. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1238-6 · Cited by 10
Lau, Q. C., Achenbach, T. V., Borchers, O., Müller, R., & Slater, E. P. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002753670229 · Cited by 10
“…considerable attention as promising therapeutic agents for the treatment of human diseases because they enable the ablation of specific disease-associated gene products on a rational basis (Agrawal and Zhao, 1998; Galderisi et al., 1999; Stein, 1999; Agrawal and Kandimalla, 2000; Crooke, 2000).”
Ueno, Y., Tomino, K., Sugimoto, I., & Matsuda, A. (2000) · Tetrahedron · doi:10.1016/s0040-4020(00)00705-5 · Cited by 9
Lipid-Mediated Introduction of Peptide Nucleic Acids Into Cells
Braasch, D. A., & Corey, D. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-290-2:211 · Cited by 9
Transcriptional tools for aging research
Case, C. C. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00178-1 · Cited by 8
Oligonucleotides as Radiopharmaceuticals
Tavitian, B. (2006) · Springer eBooks · doi:10.1007/3-540-26809-x_1 · Cited by 7
PREDICTION OF ANTISENSE OLIGONUCLEOTIDE EFFICACY USING AGGREGATE MOTIFS
Sipes, T., & Freier, S. M. (2008) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720008003795 · Cited by 6
“effective antisense molecule.(2,3) Some estimates from the literature indicate that less than one out of ten randomly chosen antisense oligonucleotides are actually active,(1,4) which explains why researchers have turned to utilizing computational modeling techniques to increase the chances of producing more active ol…”
BackgroundApplication of 2-Amino-6-Vinylpurine As an Efficient Agent for Conjugation of Oligonucleotides
Ali, M. M., Nagatsugi, F., Sasaki, S., Nakahara, R., & Maëda, M. (2006) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770500446873 · Cited by 6
(2000) · Nature Genetics · doi:10.1038/79826 · Cited by 6
Wang, Y., Shen, J.-N., Shang, X., Wang, J., Li, J., Yin, J., & Zou, C. (2011) · Tumor Biology · doi:10.1007/s13277-011-0183-4 · Cited by 5
“[63] suggested that only one in eight ASOs was effective at the very best.”
BackgroundFogarty, R. D., McKean, S. C., White, P. J., Atley, L. M., Werther, G. A., & Wraight, C. J. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002321082447 · Cited by 5
“…few of these has an antisense mechanism been clearly demonstrated, with some early reports of apparent antisense inhibition later being shown to be independent of specific hybridization with target mRNA (reviewed by Krieg and Stein, 1995; Stein, 1995, 1996, 1998, 1999; Eckstein et al., 1996).”
Chemistry of Antisense Oligonucleotides
Noe, C. R., & Kaufhold, L. (2000) · Methods and principles in medicinal chemistry · doi:10.1002/9783527613403.ch9 · Cited by 6
Ueno, Y., Karino, N., & Matsuda, A. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000684 · Cited by 4
Progress of Antisense Technology Applied in Metabolic Regulation of Bacteria
Li, Q., XU, X., YANG, J., Nie, Q. H., & Xian, M. (2008) · Chinese journal of biotechnology/Shengwu gongcheng xuebao · doi:10.1016/s1872-2075(08)60069-2 · Cited by 3
Ueno, Y., Ishihara, S., Ito, Y., & Kitade, Y. (2006) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770600684175 · Cited by 1
Sun, Y., Duan, M., Lin, R., Wang, D., Li, C., Bo, X., & Wang, S. (2006) · PubMed · Cited by 1
Targeted Downregulation of TGF-β2 with AP 12009 in Tumor Therapy
Schlingensiepen, K., Jachimczak, P., Fischer-Blass, B., Fischer, D., Specht, H., Schmaus, S., & Schlingensiepen, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_38
Antisense Nucleic Acids in Biotechnology
Delihas, N. (2001) · Wiley eBooks · doi:10.1038/npg.els.0000984
BACTERIAL GENE EXPRESSION INHIBITION WITH ANTISENSE PEPTIDE NUCLEIC ACIDS
Dryselius, R. (2005) · Figshare
Low detection of exon skipping in mouse genes orthologous to human genes on chromosome 22
Chern, T.-M. (2002) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Fletcher, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732298839.793560194
Radiolabelled Oligonucleotides for Evaluation of in vivo Hybridisation Utilising PET Methodology
Lendvai, G. (2007) · DiVA (Digitala Vetenskapliga Arkivet)
Metadata
- Authors
- Stein, C. A.
- Affiliations
- Columbia University (US)
- Corresponding author
- Stein, C.A.
- ORCID
- Stein, C.A.
- Venue
- Nature Biotechnology
- Published
- 1999-03
- Volume
- 17
- Issue
- 3
- Pages
- 209-209
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- DOI
- 10.1038/6909
- OpenAlex
- W1584948423
- Cited by
- 68
- References
- 12
- Citations by year
- 2024: 1 · 2022: 2 · 2021: 1 · 2019: 2 · 2017: 1 · 2016: 1 · 2013: 1 · 2012: 2
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- antisense oligonucleotides, oligonucleotide chemistry, oligonucleotide stability, antisense drug development, antisense therapy, antisense regulation
- MeSH terms
- Biotechnology, Thionucleotides, Oligonucleotides, Antisense
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.